An Exposure Model Framework for Signal Detection based on Electronic Healthcare Data

Fuente: arXiv
Saved in:
Bibliographic Details
Main Authors: Dijkstra, Louis, Schink, Tania, Foraita, Ronja
Format: Preprint
Published: 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866914764725157888
author Dijkstra, Louis
Schink, Tania
Foraita, Ronja
author_facet Dijkstra, Louis
Schink, Tania
Foraita, Ronja
contents Despite extensive safety assessments of drugs prior to their introduction to the market, certain adverse drug reactions (ADRs) remain undetected. The primary objective of pharmacovigilance is to identify these ADRs (i.e., signals). In addition to traditional spontaneous reporting systems (SRSs), electronic health (EHC) data is being used for signal detection as well. Unlike SRS, EHC data is longitudinal and thus requires assumptions about the patient's drug exposure history and its impact on ADR occurrences over time, which many current methods do implicitly. We propose an exposure model framework that explicitly models the longitudinal relationship between the drug and the ADR. By considering multiple such models simultaneously, we can detect signals that might be missed by other approaches. The parameters of these models are estimated using maximum likelihood, and the Bayesian Information Criterion (BIC) is employed to select the most suitable model. Since BIC is connected to the posterior distribution, it servers the dual purpose of identifying the best-fitting model and determining the presence of a signal by evaluating the posterior probability of the null model. We evaluate the effectiveness of this framework through a simulation study, for which we develop an EHC data simulator. Additionally, we conduct a case study applying our approach to four drug-ADR pairs using an EHC dataset comprising over 1.2 million insured individuals. Both the method and the EHC data simulator code are publicly accessible as part of the R package https://github.com/bips-hb/expard.
format Preprint
id arxiv_https___arxiv_org_abs_2404_14213
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle An Exposure Model Framework for Signal Detection based on Electronic Healthcare Data
Dijkstra, Louis
Schink, Tania
Foraita, Ronja
Methodology
Despite extensive safety assessments of drugs prior to their introduction to the market, certain adverse drug reactions (ADRs) remain undetected. The primary objective of pharmacovigilance is to identify these ADRs (i.e., signals). In addition to traditional spontaneous reporting systems (SRSs), electronic health (EHC) data is being used for signal detection as well. Unlike SRS, EHC data is longitudinal and thus requires assumptions about the patient's drug exposure history and its impact on ADR occurrences over time, which many current methods do implicitly. We propose an exposure model framework that explicitly models the longitudinal relationship between the drug and the ADR. By considering multiple such models simultaneously, we can detect signals that might be missed by other approaches. The parameters of these models are estimated using maximum likelihood, and the Bayesian Information Criterion (BIC) is employed to select the most suitable model. Since BIC is connected to the posterior distribution, it servers the dual purpose of identifying the best-fitting model and determining the presence of a signal by evaluating the posterior probability of the null model. We evaluate the effectiveness of this framework through a simulation study, for which we develop an EHC data simulator. Additionally, we conduct a case study applying our approach to four drug-ADR pairs using an EHC dataset comprising over 1.2 million insured individuals. Both the method and the EHC data simulator code are publicly accessible as part of the R package https://github.com/bips-hb/expard.
title An Exposure Model Framework for Signal Detection based on Electronic Healthcare Data
topic Methodology
url https://arxiv.org/abs/2404.14213